文献速递皮肤肿瘤皮肤感染

HIV患者皮肤癌风险:丹麦全国队列研究

Risk of skin cancer in patients with HIV: A Danish nationwide cohort study.
PubMed 文献 · J Am Acad Dermatol · 2018-03-26

该匹配的全国人群队列研究比较了丹麦HIV队列中4280例HIV患者与背景人群的皮肤癌风险。HIV患者基底细胞癌和鳞状细胞癌风险升高,发病率比分别为1.79(95%CI 1.43-2.22)和5.40(95%CI 3.07-9.52),黑色素瘤风险未升高。低最低点CD4细胞计数与鳞状细胞癌风险升高相关,基底细胞癌风险升高仅限于男男性行为者。

要点

  • HIV患者基底细胞癌风险升高,发病率比1.79(95%CI 1.43-2.22)。
  • HIV患者鳞状细胞癌风险升高,发病率比5.40(95%CI 3.07-9.52)。
  • 低最低点CD4细胞计数与鳞状细胞癌风险升高相关。

核心结论

  • HIV患者基底细胞癌和鳞状细胞癌风险升高。
  • 低最低点而非当前CD4细胞计数作为免疫抑制标志与鳞状细胞癌风险升高相关。

研究设计与样本

  • 匹配的全国人群队列研究,比较丹麦HIV队列中4280例HIV患者与背景人群队列的皮肤癌风险。
  • 按免疫抑制水平和传播途径进行分析。

主要发现

  • HIV患者基底细胞癌发病率比为1.79(95%CI 1.43-2.22),高于背景人群。
  • HIV患者鳞状细胞癌发病率比为5.40(95%CI 3.07-9.52),高于背景人群。
  • 未观察到黑色素瘤风险升高。
  • 低最低点CD4细胞计数与鳞状细胞癌风险升高相关。
  • HIV患者基底细胞癌风险升高仅限于男男性行为者。

局限性

  • 本研究为观察性研究,且纳入的黑色素瘤患者数量较少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The risk of skin cancer in patients with HIV has not been extensively studied. OBJECTIVE: We sought to determine the risk of skin cancer in patients with HIV and compare it with the risk in the background population. METHODS: In a matched, nationwide, population-based cohort study, we compared the risk of skin cancer in 4280 patients with HIV from the Danish HIV cohort study with a background population cohort, according to the level of immunosuppression and route of transmission. Primary outcomes were time to first basal cell carcinoma (BCC), squamous cell carcinoma (SCC), or malignant melanoma. RESULTS: Patients with HIV had an increased risk of BCC and SCC with incident rate ratios of 1.79 (95% confidence interval 1.43-2.22) and 5.40 (95% confidence interval 3.07-9.52), respectively, compared with the background population. We observed no increased risk of malignant melanoma. Low nadir CD4 cell count was associated with an increased risk of SCC. The increased risk of BCC among patients with HIV was restricted to men who had sex with men. LIMITATIONS: This study was observational and included a small number of patients with melanoma. CONCLUSION: Patients with HIV have an increased risk of BCC and SCC. Low nadir, but not current, CD4 cell count as a marker of immunosuppression was associated with an increased risk of SCC.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Omland SH, Ahlström MG, Gerstoft J, et al. Risk of skin cancer in patients with HIV: A Danish nationwide cohort study. J Am Acad Dermatol. 2018. PMID: 29588249. doi:10.1016/j.jaad.2018.03.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。